Health

BIORCHESTRA Wins Grand Prize in 2023 Merck Advance Biotech Grant Program

* Recognition of outstanding in-vivo outcomes from a lead RNA program in CNS * Underpinned by proprietary IV-formulated, Brain-targeting Ribonucleic Acid Interference (RNAi) Nanomedicine (BTRiNTM) platform * BIORCHESTRA to receive in-kind products and services from Merck Group CAMBRIDGE, Mas...

2023-07-17 21:28 2017

ALZHEIMER'S ASSOCIATION STATEMENT ON DONANEMAB PHASE 3 DATA REPORTED AT AAIC 2023

AMSTERDAM, July 17, 2023 /PRNewswire/ -- The data reported today by Eli Lilly from theTRAILBLAZER-ALZ 2 clinical trial of donanemab in early symptomatic Alzheimer's disease demonstrate an important  advancement in Alzheimer's research and treatment. The full Phase 3 data was reported at the Alzh...

2023-07-17 21:15 2200

GeneQuantum and InxMed have reached a technology licensing collaboration, providing strong support for innovative ADC drug research and development

SUZHOU, China, July 17, 2023 /PRNewswire/ -- On July 14, 2023, GeneQuantum, a leading pioneer committed to innovative bioconjugation technology, and InxMed, a clinical-stage biotechnology company dedicates on developing innovative therapies targeting drug resistance for hard-to-treat solid tumors...

2023-07-17 17:00 1470

Precedential US Federal Court Decision Hands SNIPR Biome a win in patent appeal over Rockefeller University for CRISPR-Cas microbial gene editing

* Five contested patents held by SNIPR remain in place  * Precedential ruling means that SNIPR's patent portfolio will not be subject to any further interference and will not be judged by the old first-to-invent standard COPENHAGEN, Denmark, July 17, 2023 /PRNewswire/ -- SNIPR Biome ApS, the ...

2023-07-17 15:09 2099

TradeWinds Brings Taiwanese Medical Device Manufacturers to Medicall Exhibition in Chennai

TAIPEI, July 17, 2023 /PRNewswire/ -- TradeWinds is a leading media & exhibition agency in the health field. We are pleased to announce that these two Taiwanese medical device manufacturers will participate inMedicall at Chennai Trade Center from 28-30 July

2023-07-17 12:30 2505

Antengene Announces XPOVIO® Regulatory Approval in Hong Kong for the Treatment of Relapsed and/or Refractory Multiple Myeloma

* XPOVIO® (selinexor) is the first and only XPO1 inhibitor approved in Hong Kong * XPOVIO® has received regulatory approvals in 41 countries and regions  includingthe United States, Israel, the United Kingdom, the European Union (the 27 member countries includingFrance and Italy), Canada, Norw...

2023-07-17 08:30 2694

MGI Empowers Life Sciences Industry with Revolutionary What If Campaign at XXIIIrd International Congress of Genetics

MELBOURNE, Australia, July 17, 2023 /PRNewswire/ -- MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, today announced the launch of a global brand campaign titled "What If?" at the XXIII International Congress of Genetics (ICG), a five-yearly...

2023-07-17 07:00 2263

Red Marrow Peptide-A Major Breakthrough in Human Health Engineering

BEIJING, July 14, 2023 /PRNewswire/ -- 1.8 g! This figure refers to the weight of red marrow which can be extracted from a 100 kg young yak growing in no-human zone ofQinghai and enjoys the reputation of "the key of cardiovascular health". It is called the most perfect "blood scavenger", ...

2023-07-14 12:51 2062

Modernising Philanthropy: Kidney Dialysis Foundation Embraces Technology with over 50 GivePlease Donation Terminals Islandwide for Flag Day Fundraising

Changing the fundraising landscape, one donation terminal at a time.   SINGAPORE, July 14, 2023 /PRNewswire/ -- The Kidney Dialysis Foundation (KDF) is set to revolutionise its annual Flag Day event on15 July 2023 by introducing over 50 cutting-edge GivePlease donation terminals alongside traditi...

2023-07-14 09:00 4057

Nona Biosciences Announces Business Update of Collaboration on Antibody Drug Conjugate (ADC) with DualityBio

CAMBRIDGE, Mass., July 13, 2023 /PRNewswire/ -- Nona Biosciences, a wholly-owned subsidiary of HBM Holdings Limited, committed to cutting-edge antibody technology innovation and provider of integrated solutions from "Idea to IND" (I to ITM) announced that, DualityBio, a collaborator of Nona Bios...

2023-07-14 08:29 1851

Menarini Silicon Biosystems announces the launch of its new CELLSEARCH® CTC test with the DLL3 biomarker for small cell lung cancer

This new CELLSEARCH Circulating Tumor Cell (CTC) test is now available as a Research Use Only (RUO) lab service inNorth America and Europe. It is currently intended for basic and pharmaceutical research and it is the latest example of how Menarini Silicon Biosystems continues its development of c...

2023-07-13 20:00 2982

Harbour BioMed Announces 2023 Interim Results Positive Profit Alert with the Enhancement of Value Driven by Innovation

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, July 13, 2023 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunol...

2023-07-13 18:11 4109

FWD Group ranked number six in 2023 MDRT rankings

HONG KONG, July 13, 2023 /PRNewswire/ -- FWD Group Holdings Limited ("FWD Group") ranked number six in the2023 Million Dollar Round Table ("MDRT") Top 10 Multinational Companies rankings, retaining its position from last year. In Thailand and the Philippines, FWD ranked number two for MDR...

2023-07-13 16:55 2450

Gustave Roussy and THERYQ: France welcomes the first FLASH radiotherapy machine to treat patients

PEYNIER, France, July 13, 2023 /PRNewswire/ -- Gustave Roussy and THERYQ announce a strategic and structuring partnership to roll out and assess FLASH technology for radiotherapy. French medical technology company THERYQ, specializing in particle accelerators and radiotherapy systems, has provide...

2023-07-13 15:30 2626

Dr Catarina Ang to Join Genea Fertility's new Melbourne City clinic

MELBOURNE, Australia, July 13, 2023 /PRNewswire/ -- Genea Fertility is pleased to announce Melbourne Fertility Specialist DrCatarina Ang is joining the world-leading fertility provider. Dr Ang, an experienced gynaecologist and obstetrician, will consult from Genea Fertility's newMelbourne City cl...

2023-07-13 10:32 2535

Yili Innovation Center Europe, the Institute for Manufacturing and StartLife in the Netherlands jointly hold the Open Innovation Forum

-To Enhance the Development of a Global Health Ecosystem WAGENINGEN, Netherlands, July 13, 2023 /PRNewswire/ -- From July 5 to 6, 2023 , the Open Innovation Forum was held on the campus of Wageningen University and Research (WUR), one of the world's top higher education institutions focusing on a...

2023-07-13 09:06 3074

Race executes agreement with Ardena for GMP manufacturing of RC220

* Race Oncology executes agreement with leading global contract development and manufacturing organisation, Ardena as additional partner for GMP manufacturing of flagship RC220 bistanrene formulation * Ardena has a long track record of providing sterile injectable products for all stages of c...

2023-07-13 07:30 2870

NeuroXess Documents Its Multiple Achievements in Brain-Computer Interface Research at The 2023 World Artificial Intelligence Conference

SHANGHAI, July 12, 2023 /PRNewswire/ -- On the afternoon of July 6, a forum dedicated to advances in brain-computer intelligence was held at the Shanghai World Expo Exhibition & Convention Center as a part of the 2023 World Artificial Intelligence Conference. The forum was held under the aegis of...

2023-07-12 21:41 2875

Sirnaomics to Present Latest Developments on Two Proprietary Delivery Platforms at Upcoming Industry Conferences

HONG KONG, Germantown, Md. and SUZHOU, China, July 12, 2023 /PRNewswire/ --  Sirnaomics Ltd.(the "Company", stock code: 2257, together with its subsidiaries, the"Group" or "Sirnaomics"), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, hereby...

2023-07-12 20:45 2718

Race executes agreement with Ardena for GMP manufacturing of RC220

* Race Oncology executes agreement with leading global contract development and manufacturing organisation, Ardena as additional partner for GMP manufacturing of flagship RC220 bistanrene formulation * Ardena has a long track record of providing sterile injectable products for all stages of c...

2023-07-12 19:30 2264
1 ... 221222223224225226227 ... 858